METASTATIC PROSTATE NEUROENDOCRINE CARCINOMA
Clinical trials for METASTATIC PROSTATE NEUROENDOCRINE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PROSTATE NEUROENDOCRINE CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PROSTATE NEUROENDOCRINE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radioactive 'Tumor-Seeker' drug tested for Tough-to-Treat prostate cancer
Disease control Recruiting nowThis study is testing an experimental radioactive drug called lutetium Lu 177 dotatate for men with an aggressive form of prostate cancer that has spread and developed neuroendocrine features. The drug is designed to find and deliver radiation directly to cancer cells. The main g…
Matched conditions: METASTATIC PROSTATE NEUROENDOCRINE CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC
-
New scan aims to spot elusive prostate cancer
Diagnosis Recruiting nowThis study is testing a new type of PET scan to see if it can better detect aggressive forms of advanced prostate cancer that are difficult to find with current standard scans. Researchers will enroll about 30 men with this specific type of cancer to compare the new scan against …
Matched conditions: METASTATIC PROSTATE NEUROENDOCRINE CARCINOMA
Phase: PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Diagnosis
Last updated Mar 23, 2026 15:16 UTC